Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor
Zou, Helen Y, Li, Qiuhua, Lee, Joseph H, Arango, Maria E, Burgess, Kristina, Qiu, Ming, Engstrom, Lars D, Yamazaki, Shinji, Parker, Max, Timofeevski, Sergei, Cui, Jingrong Jean, McTigue, Michele, Los, Gerrit, Bender, Steven L, Smeal, Tod, Christensen, James G
Published in Molecular cancer therapeutics (01.04.2012)
Published in Molecular cancer therapeutics (01.04.2012)
Get full text
Journal Article
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain
Bagal, Sharan K, Andrews, Mark, Bechle, Bruce M, Bian, Jianwei, Bilsland, James, Blakemore, David C, Braganza, John F, Bungay, Peter J, Corbett, Matthew S, Cronin, Ciaran N, Cui, Jingrong Jean, Dias, Rebecca, Flanagan, Neil J, Greasley, Samantha E, Grimley, Rachel, James, Kim, Johnson, Eric, Kitching, Linda, Kraus, Michelle L, McAlpine, Indrawan, Nagata, Asako, Ninkovic, Sacha, Omoto, Kiyoyuki, Scales, Stephanie, Skerratt, Sarah E, Sun, Jianmin, Tran-Dubé, Michelle, Waldron, Gareth J, Wang, Fen, Warmus, Joseph S
Published in Journal of medicinal chemistry (09.08.2018)
Published in Journal of medicinal chemistry (09.08.2018)
Get full text
Journal Article
Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1 fusion-positive non-small cell lung cancer (TRIDENT-1 study)
Cho, Byoung Chul, Drilon, Alexander E., Doebele, Robert Charles, Kim, Dong-Wan, Lin, Jessica Jiyeong, Lee, Jeeyun, Ahn, Myung-Ju, Zhu, Viola Weijia, Ejadi, Samuel, Camidge, D. Ross, Liu, Yuwei Juliet, Stopatschinskaja, Shanna, Cui, Jingrong Jean, Hyman, David Michael, Ou, Sai-Hong Ignatius, Shaw, Alice Tsang
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
A phase 1 study of the next-generation ALK/ROS1/TRK inhibitor ropotrectinib (TPX-0005) in patients with advanced ALK/ROS1/NTRK+ cancers (TRIDENT-1)
Drilon, Alexander E., Ou, Sai-Hong Ignatius, Cho, Byoung Chul, Kim, Dong-Wan, Lee, Jeeyun, Lin, Jessica Jiyeong, Zhu, Viola Weijia, Kim, HyeRyun, Kim, Tae Min, Ahn, Myung-Ju, Camidge, D. Ross, Lim, John K.C., Stopatschinskaja, Shanna, Cui, Jingrong Jean, Hyman, David Michael, Doebele, Robert Charles, Shaw, Alice Tsang
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
AXL and CDCP1: A roadmap of innate resistance in EGFR mutant NSCLC
Karachaliou, Niki, Chaib, Imane, Cardona Zorrilla, Andres Felipe, Berenguer, Jordi, Bracht, Jillian, Yang, Jie, Cai, Xueting, Wang, Zhigang, Drozdowskyj, Ana, Attili, Ilaria, Rodríguez, July Katherine, Rojas Puentes, Luis Leonardo, Viteri Ramirez, Santiago, Ou, Sai-Hong Ignatius, Mok, Tony, Bivona, Trever Grant, Ono, Mayumi, Cui, Jingrong Jean, Cao, Peng, Rosell, Rafael
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article